Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs

The pharmacological treatment of cholangiocarcinoma (CCA) is often hampered by tumor resistance. Improving our understanding of this issue is crucial for developing strategies that can overcome drug refractoriness. We have established and characterized two novel human cell sublines derived from extr...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin Delgado-Calvo, Elisa Lozano, Oscar Briz, Candela Cives-Losada, Jose J. G. Marin, Rocio I. R. Macias
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/14/3053
Tags: Add Tag
No Tags, Be the first to tag this record!